Alison Schecter, MD, CMO/CEO
Episode 7 of BioByteas by Windsor Bux welcomes Alison Schecter, MD, CMO/CEO
Alison D. Schecter, an experienced biotech executive, shares insights and advice on leadership in the biotech industry. She discusses the importance of understanding both the science and commercial aspects of biotech businesses. Schecter emphasizes the value of hands-on experience in clinical trials and the ability to understand the language and challenges of the field. She also highlights the significance of building relationships, fostering an innovative culture, and maintaining transparency and respect within the organization. Schecter shares her experiences navigating challenges, including the impact of COVID-19 on clinical trials.


  • Successful biotech leaders understand both the science and commercial aspects of the industry.
  • Hands-on experience in clinical trials is valuable for biotech executives.
  • Building relationships and maintaining transparency and respect are crucial for success.
  • Navigating challenges, such as the impact of COVID-19, requires trust, communication, and adaptability.

You can also listen to this podcast on Spotifty:

Welcome to BioBytes – Windsor Bux, where we bring you exclusive interviews with the movers and shakers of the biotech and pharmaceutical industry. Join us as we delve into the experiences and valuable insights of leading executives, exploring how they’re shaping the future and making a difference. Get ready for compelling conversations that will expand your knowledge and inspire your own journey in this exciting field!